Are you a practitioner?

Join our network
join us illustration
Psychiatrist
Dr Kalypso Markopoulou Psychiatrist: Book an online appointment

Markopoulou Kalypso MD, PhD

Psychiatrist Athens

9.8 | 1 review
  • 1 '

Remote availability

Next availability
Book a Video Consultation

Why she is suitable for you




The description was edited by the doctoranytime team, based on verified information.

Experience

Relative Experience

  • Treatment of ADHD
1 patients' recommendations

Services

Costs are indicative and will be determined on a case by case basis

Patient Reviews

9.8
From 1 review

Real reviews for real people

Investigated my case in depth
10
Trustworthy
10
Experienced & qualified
10
Punctual
9
Approachable & friendly
10

Reviews are written by people who had an appointment with a specialist and want to share their experience. Learn how we ensure their authenticity

  • All (1)
  • Positive (1)
  • Neutral (0)
  • Negative (0)
9.8
Νικόλαος • 1 review
Με βοηθησε να καταλαβω περισσοτερα για τον αυτισμο και τον αυτισμο σε σχεση με ΔΕΠΥ. Μου ελυσε τις αποριες που ειχα και ηταν ενημερωτικη με ο,τι χρειαστηκα.
07 May 2026

Contact and location

Payment Methods

  • Payment Methods

    • Bank Card
    • Pay with Klarna

    Appointment Policy

    • Online Payment

      Payment is made once you book the appointment online.

    • Cancellation

      You won’t be charged if you or your doctor cancel up to 24 hours before the appointment. For more information please read our cancellation and refund policy.

Curriculum Vitae and Career

Studies

  • MD, National and Kapodistrian University of Athens, School of Medicine
  • PhD, King's College, HPA Axis Dysfunction in Treatment Resistant Affective Disorders

Academic research and publications

  • Comparison of patients of hypothalamo-pituitary-adrenal function in treatment resistant unipolar and bipolar depression. Markopoulou K and Fischer S, Papadopoulos A, Poon L, Rane L, Fekadu A, Cleare AJ. Translational Psychiatry, 2021 April 26; 11(1):244.
  • What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. Fekadu A, Wooderson SC, Markopoulou K, Donaldson C, Papadopoulos A, Cleare AJ. J Affect Disord. 2009 Jul; 116(1-2):4-11.
  • A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. Fekadu A, Wooderson S, Donaldson C, Markopoulou K, Masterson B, Poon L, Cleare AJ. J Clin Psychiatry. 2009 Feb; 70(2):177-84.
  • Discrepancy between subjective and objective severity in treatment-resistant
  • depression: Prediction of treatment outcome. L.J. Rane, A. Fekadu, S. Wooderson, L. Poon, K. Markopoulou, A.J. Cleare. Journal of Psychiatric Research 2010 Nov; 44(15):1082-7.
  • Prospective evaluation of specialist inpatient treatment for refractory affective disorders. Wooderson SC, Juruena MF, Fekadu A, Commane C, Donaldson C, Cowan M, Tomlinson M, Poon L, Markopoulou K, Rane L, Donocik J, Tunnard C, Masterson B, Cleare AJ. J Affective Disorders 2011 Jun; 131(1-3):92-103.
  • Long term impact of residual symptoms in treatment-resistant depression. Abebaw Fekadu, Sarah C Wooderson, Lena J Rane, Kalypso Markopoulou, Lucia Poon, Anthony J Cleare. Canadian Journal of Psychiatry 2011 Sep; 56(9):549-57.
  • Psychological and physiological effects of caring for patients with treatment-resistant depression. L. J. Rane, A. Fekadu, A. S. Papadopoulos, S. C. Wooderson, L. Poon, K. Markopoulou, A. J. Cleare. Psychological Medicine 2011, 0, 1–9.
  • The ratio of cortisol/DHEA in treatment resistant depression. Markopoulou K, Papadopoulos A, Juruena MF, Poon L, Pariante CM, Cleare AJ. Psychoneuroendocrinology, 2009 Jan; 34(1):19-26.
  • Prediction of longer term outcome of treatment resistant depression in tertiary care. Fekadu A, Rane L, Wooderson S, Markopoulou K, Poon L, Cleare A. BJPsych, 2012 Nov, vol 201, no 5.
  • The Maudsley staging method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms. Fekadu A, Wooderson SC, Markopoulou K, Cleare AJ. J Clin Psychiatry. 2009 Jul; 70(7): 952-7.
  • Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment resistant affective disorders. Wooderson SC, Fekadu A, Markopoulou K, Rane LJ, Poon L, Juruena MF, Strawbridge R, Cleare AJ. J Affect Disord. 2014 Sep;166:334-42.
  • Τhe impact of childhood adversity on suicidality and clinical course in treatment resistant depression. Tunnard C, Rane LJ, Wooderson SC, Markopoulou K, Poon L, Fekadu A, Juruena M, Cleare AJ. J Affect Disord. 2014 Jan;152-154:122-30.
  • Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression. Vergunst FK, Fekadu A, Wooderson SC, Tunnard CS, Rane LJ, Markopoulou K, Cleare AJ. Psychiatry Res. 2013 May 30;207(3):143-9.
  • SAD Biennial Conference, Vancouver, April 2010.
  • ᾽Longer-term outcome in treatment-resistant depression: Prediction of remission, recovery and episode persistence.’ A.J. Cleare, A. Fekadu, L.J. Rane, S.C Wooderson, K. Markopoulou, L. Poon. Journal of Affective Disorders, April 2010.
  • Longer-term outcome of treatment resistant depression after specialist, multimodal, inpatient treatment: a prospective follow up study. S.C. Wooderson, A. Fekadu, M.F. Juruena, L.J. Rane, K. Markopoulou, A.J. Cleare.
  • Carer burden in treatment-resistant depression: Disruption of the cortisol awakening response and relation to treatment outcome. L.J. Rane, A. Fekadu, A.S. Papadopoulos, S. Wooderson, L. Poon, K. Markopoulou, A.J. Cleare.
  • British Association of Psychopharmacology 25 – 28 July 2010, Harrogate, UK. Treatment Resistant Depression and the CAR (Cortisol Awakening Response). Markopoulou K, Papadopoulos A, Poon L, Cleare A. King’s College London, Inst of Psychiatry, UK; The National Affective Disorders Unit, South London and Maudsley UK. Abstract Supplement to Journal of Psychopharmacology Volume 24, Supplement 3, 6 August 2010.
  • The Salivary Ratio of Cortisol/DHEA in Treatment Resistant Unipolar Depression. Markopoulou K, Papadopoulos A, Poon L, Cleare A. King’s College London, Inst of Psychiatry, UK; The National Affective Disorders Unit, South London and Maudsley UK. Abstract Supplement to Journal of Psychopharmacology Volume 24, Supplement 3, 6 August 2010.
  • British Association of Psychopharmacology, Oxford, UK. The Ratio of Cortisol/DHEA in Chronic Fatigue Syndrome. Markopoulou K, Papadopoulos A, Cleare AJ. Abstract Supplement to Journal of Psychopharmacology Volume 23 Number 6 August 2009.
  • ffect of Specialist Inpatient Treatment for Refractory Affective Disorders on Subsequent Service Use: A long term mirror image study. Cleare AJ, Wooderson S, Markopoulou K, Rane L, Poon L, Fekadu A., Section of Neurobiology of Mood Disorders, Inst of Psychiatry, King’s College London; National Affective Disorders Unit, South London and Maudsley NHS Trust. Abstract Supplement to Journal of Psychopharmacology Volume 23 Number 6 August 2009.
  • 2 years of antipsychotic use in 1st episode services”, Markopoulou K, Matthiasson P, Gafoor R, Power P, McGuire PK. Vancouver Canada, 2004.
Doctoranytime is an end-to-end solution that assists the user from the moment they experience a health symptom until the moment it is resolved, by enabling them to find the specialist they need, request guidance via chat and talk to them via video call. The information provided has been filled in by Markopoulou Kalypso and edited by the doctoranytime team.
Log in or register to continue
Are you a new user? Register for free
Log in or register to continue

Continue with

or register with your email address

The password should contain at least 6 characters and 1 capital letter
Are you a registered user?
Create a new password

Enter the email you used to register in doctoranytime and we'll send you a link to create new password

Your data is in good hands
doctor-graphic doctor-graphic

doctoranytime takes your health as well as your data protection very seriously!

In order to ensure you that:

  • you will continue to get the best possible treatment from the affiliated doctors and diagnostic centers
  • you will continue to book your appointments easily and quickly by having at the same time the right of evaluation
  • we will be able to contact you immediately in case of a change in your appointment
  • you will continue to receive our newsletter and health suggestions that may interest you

it is essential for us to collect and process your personal data to the extent that you allow.

For this reason, we would like to inform you that we take all the necessary measures in order to protect your personal data, according to the New European General Data Protection Regulation (“GDPR”), the terms of the doctoranytime Privacy Policy (that you can read in detail here) and the law requirements.

If you have any questions regarding your privacy protection by doctoranytime or in case you wish to exercise your GDPR rights (information, access, correction, deletion, limitation of processing, portability of your data, objection and right to lodge a complaint with the Personal Data Protection Authority) you can contact the Data Protection Officer of doctoranytime on: [email protected].

Terms of Use

Congratulations!!

Your registration has completed.